Altered protein expression in endometrial carcinogenesis

Cancer Letters

Volumn 226, Issue 2, 2005, Pages 101-106

  Yoshizaki, Tatsuo ^a   Enomoto, Takayuki ^a   Nakashima, Ryuichi ^a   Ueda, Yutaka ^a   Kanao, Hiroyuki ^a   Yoshino, Kiyoshi ^a   Fukumoto, Masahiro ^b   Yoneda, Yoshihiro ^b   Buzard, Gregory S ^c   Murata, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SAIC FREDERICK INC   (United States)

Author keywords

Endometrial carcinoma; Proteomics; SELDI TOF MS

Indexed keywords

BIOLOGICAL MARKER; PROTEIN EC1; PROTEIN EC2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 22844450312     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.11.053     Document Type: Article

References (27)

1. C.J. Best, J.W. Gillespie, C.R. Englert, J.I. Swalwell, J. Pfeifer, and D.B. Krizman New approaches to molecular profiling of tissue samples Anal. Cell Pathol. 20 2000 1 6
2. J.D. Wulfkuhle, K.C. McLean, C.P. Paweletz, D.C. Sgroi, B.J. Trock, P.S. Steeg, and E.F. Petricoin III. New approaches to proteomic analysis of breast cancer Proteomics 1 2001 1205 1215
3. H.J. Issaq, T.D. Veenstra, T.P. Conrads, and D. Felschow The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification Biochem. Biophys. Res. Commun. 292 2002 587 592
4. M. Merchant, and S.R. Weinberger Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry Electrophoresis 21 2000 1164 1177
5. W. Wu, W. Hu, and J.J. Kavanagh Proteomics in cancer research Int. J. Gynecol. Cancer 12 2002 409 423
6. E.F. Petricoin, A.M. Ardekani, B.A. Hitt, P.J. Levine, V.A. Fusaro, and S.M. Steinberg Use of proteomic patterns in serum to identify ovarian cancer Lancet 359 2002 572 577
7. A.J. Rai, Z. Zhang, J. Rosenzweig, M. Shih Ie, T. Pham, and E.T. Fung Proteomic approaches to tumor marker discovery Arch. Pathol. Lab. Med. 126 2002 1518 1526
8. C. Rosty, L. Christa, S. Kuzdzal, W.M. Baldwin, M.L. Zahurak, and F. Carnot Identification of hepatocarcinoma-intestine-pancreas/pancreatitis- associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology Cancer Res. 62 2002 1868 1875
9. B.L. Adam, Y. Qu, J.W. Davis, M.D. Ward, M.A. Clements, and L.H. Cazares Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men Cancer Res. 62 2002 3609 3614
10. Z. Xiao, X. Jiang, M.L. Beckett, and G.L. Wright Jr. Generation of a baculovirus recombinant prostate-specific membrane antigen and its use in the development of a novel protein biochip quantitative immunoassay Protein Exp. Purif. 19 2000 12 21
11. F. Parazzini, C. La Vecchia, L. Bocciolone, and S. Franceschi The epidemiology of endometrial cancer Gynecol. Oncol. 41 1991 1 16
12. K.I. Pritchard Screening for endometrial cancer: is it effective? Ann. Intern. Med. 110 1989 177 179
13. D. Eddy ACS report on the cancer-related health checkup CA Cancer J. Clin. 30 1980 193 240
14. W. Burke, G. Petersen, P. Lynch, J. Botkin, M. Daly, and J. Garber Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium J. Am. Med. Assoc. 277 1997 915 919
15. J.I. Risinger, G.A. Dent, D. Ignar-Trowbridge, J.A. McLachlan, M.S. Tsao, M. Senterman, and J. Boyd p53 gene mutations in human endometrial carcinoma Mol. Carcinog. 5 1992 250 253
16. I.U. Ali Gatekeeper for endometrium: the PTEN tumor suppressor gene J. Natl Cancer Inst. 92 2000 861 863
17. J.I. Risinger, K. Hayes, G.L. Maxwell, M.E. Carney, R.K. Dodge, J.C. Barrett, and A. Berchuck PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics Clin. Cancer Res. 4 1998 3005 3010
18. G.L. Mutter Pten, a protean tumor suppressor Am. J. Pathol. 158 2001 1895 1898
19. G.L. Mutter, M.C. Lin, J.T. Fitzgerald, J.B. Kum, J.P. Baak, and J.A. Lees Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers J. Natl Cancer Inst. 92 2000 924 930
20. T. Enomoto, M. Inoue, A.O. Perantoni, N. Terakawa, O. Tanizawa, and J.M. Rice K-ras activation in neoplasms of the human female reproductive tract Cancer Res. 50 1990 6139 6145
21. R.F. Caduff, C.M. Johnston, and T.S. Frank Mutations of the Ki-ras oncogene in carcinoma of the endometrium Am. J. Pathol. 146 1995 182 188
22. S.F. Lax, B. Kendall, H. Tashiro, R.J. Slebos, and L. Hedrick The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways Cancer 88 2000 814 824
23. A. Berchuck, G. Rodriguez, R.B. Kinney, J.T. Soper, R.K. Dodge, D.L. Clarke-Pearson, and R.C. Bast Jr. Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease Am. J. Obstet. Gynecol. 164 1991 15 21
24. D.J. Hetzel, T.O. Wilson, G.L. Keeney, P.C. Roche, S.S. Cha, and K.C. Podratz HER-2/neu expression: a major prognostic factor in endometrial cancer Gynecol. Oncol. 47 1992 179 185
25. M.W. Riben, J.H. Malfetano, T. Nazeer, P.J. Muraca, R.A. Ambros, and J.S. Ross Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma Mod. Pathol. 10 1997 823 831
26. J.A. Williams Jr., Z.R. Wang, R.S. Parrish, L.J. Hazlett, S.T. Smith, and S.R. Young Fluorescence in situ hybridization analysis of HER-2/neu, c-myc, and p53 in endometrial cancer Exp. Mol. Pathol. 67 1999 135 143
27. E.C. Yang, J. Guo, G. Diehl, L. DeSouza, M.J. Rodrigues, and A.D. Romaschin Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10 J. Proteome Res. 3 2004 636 643